Gane PML maganin cututtuka vs. Wadanda na MS Rushewa
Maganin ci gaba mai mahimmanci (PML), wata cuta ce mai ciwo amma sau da yawa wanda cutar ta JC ta haifar . Wannan kwayar cutar ana gudanar da ita ta hanyar tsarin rigakafinka don haka ba zai iya haifar da lalacewa ba.
Duk da haka, idan cutar ta cutar da ku, irin su HIV / AIDs , cutar sankarar bargo , lymphoma, ko wani ciwon daji, ko kuma magance ciwon daji, kwayar cutar zata iya mayar da cutar da kuma lalata kwakwalwarka.
Cutar kwakwalwa ta hanyar PML zai iya haifar da wasu alamun alamun.
Yayin da PML ya kasance mai ban sha'awa, yana da damuwa idan kana da maganin sclerosis (MS) saboda wasu magungunan rigakafin da ke amfani da su don magance cutar sun kara yawan halayyar PML na bunkasa.
Tysabri (natalizumab) ya kasance yana haɗari da babbar haɗari ga PML. Duk da haka, wasu magunguna na MS na iya haifar da haɗari, ciki harda Gilenya (fingolimod), Tecfidera (dimethyl fumarate), Ocrevus (ocrelizumab), da kuma yiwu wasu.
PML cututtuka
MS kanta ba ta ƙara yawan haɗari ga PML ba. Amma idan kai ko wanda kake ƙauna yana shan magani na gyaran cututtuka wanda ke rufe tsarin rigakafi, sanin kanka da bayyanar da PML ya ba ka damar zama mai ba da shawara da kuma sanar da shi a saka idanu don wannan gagarumin wahala.
Kamar misalin MS, waɗanda suke da alaka da PML sun bambanta, dangane da yankin (s) na kwakwalwa ya shafi.
Kwayar cututtuka na iya haɗawa da:
- Rashin rauni, sau da yawa a gefe ɗaya na jiki
- Rashin ƙwaƙwalwar tunani, wanda sau da yawa yana nuna rikicewa da / ko ƙwaƙwalwar ajiya
- Difficulty magana
- Daidaitaccen rashin daidaituwa, yawanci dandanawa kamar ƙyama ko matsaloli masu tafiya
- Matsaloli na gani, kamar hangen nesa ko ba a gani a fili a wani yanki na filinku na gani ba
- Canje-canje na mutum
- Abubuwa masu ban sha'awa ko hasara na jin dadi a cikin jikinka
- Riƙe, ko da yake wannan ya zama sananne
PML vs. MS Relapse
Ana nuna alamun bayyanar cutar PML daga wadanda aka dawo da MS. Wannan ba abin mamaki bane saboda cututtukan biyu suna haifar da lalata, ma'anar lalata abin da ke kewaye da jijiyoyi. Lalacewar wannan abu mai tsaro, wanda ake kira myelin, ya rushe watsa sakonni a tsakanin kwakwalwarka da jiki.
Saboda bayyanar cutar PML da sake dawowa MS zai iya kasancewa daidai, yana da wuya a gane PML a farkon farkon cutar. Wannan ya ce, gudun ci gaba da sababbin bayyanar cututtuka alama ce ta taimakawa wajen rarraba ko sun kasance saboda PML ko MS sake dawowa. Magunguna na PML ba su faruwa ba zato ba tsammani amma suna cigaba da cigaba a cikin kwanaki zuwa makonni.
Doctors na iya bambanta PML daga MS ta hanyar yin nazarin bayyanar cututtukan mutum. Saboda PML shine kamuwa da cutar kwakwalwa, yawanci yakan haifar da alama fiye da ɗaya ko tayarwa, alhali kuwa irin wannan alama ce ta fi dacewa da siginar MS. Duk da haka, wannan shine kawai alamar, ba wata doka mai wuya ba.
Wata hanya mai mahimmanci don rarrabe PML daga sake komawar MS shine a bincika MRI dubawa game da kwakwalwa na mutumin da ya shafa.
Kamar MS, PML yana haifar da cututtukan kwakwalwa a kan MRI, amma sun bambanta da cutar MS a cikin girman, siffar, wuri, da kuma sauran halaye.
An yi amfani da famfin ƙwaƙwalwa don jarraba ruwan ƙwayar cuta don cutar JC don tabbatar da ganewar asali na PML. A ƙarshe, wani lokaci ana yin kwakwalwa ta kwakwalwa.
Kalma Daga
Mun fahimci cewa ko da yiwuwar yiwuwar inganta PML yana damuwa sosai lokacin da kake shan magungunan MS. Idan kun kasance a kan Tysabri, Gilenya, Tecfidera, Ocrevus, ko kuma wani magani na immunosuppressant na MS da kuma lura da kowane sabon cututtuka ko kuma kara tsanantawa, tuntuɓi likitanku nan da nan.
Duk da yake waɗannan bayyanar cututtuka ba kullum nuna nuna ci gaba na PML ba, gaggawa gaggawa na kimantawa saboda wannan kamuwa da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwayar cuta tana barazana. Sakamakon asali na farko ya baka dama mafi kyau don kyakkyawan sakamako idan ka ci gaba da PML.
> Sources:
> Bloomgren G, Richman S, Hotermans C, et al. Hadarin na Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. N Engl J Med . 2012 Mayu 17; 366 (20): 1870-80.
> Greenlee JE. Ci gaba na Leukoencephalopathy (PML). A cikin: Porter RS, Kaplan JL, Lynn RB, et al. Merck Jagoran Mai Nuni .
> Maas RPPWM, Muller-Hansma AHG, Esselink RAJ, et al. Magungunan ƙwayoyin cuta da ke da nasaba da kwayoyin cutar Leukoencephalopathy: A Clinical, Radiological, and Cerebrospinal Fluid Analysis of 326 Cases. J Neurol . 2016; 263 (10): 2004-2021.
> Ƙungiyar Ƙungiya ta Ƙananan Raunuka. (2015). Ci gaba mai laushi mai yawa Leukoencephalopathy.
> Wollebo HS, White MK, Gordon J, Berger JR, Khalili K. Tsarin da Masarautar Neurotropic Polyomavirus JC. Ann Neurol . 2015 Apr; 77 (4): 560-570.